The Recombinant Profilin from Free-Living Amoebae Induced Allergic Immune Responses via TLR2
DOI: https://doi.org/10.2147/jir.s450866
IF: 4.5
2024-05-14
Journal of Inflammation Research
Abstract:Mi Kyung Park, 1 Hye-Kyung Park, 2 Hak Sun Yu 1, 3 1 Department of Parasitology and Tropical Medicine, School of Medicine, Pusan National University, Yangsan, Republic of Korea; 2 Department of Internal Medicine, School of Medicine, Pusan National University, Yangsan, Republic of Korea; 3 Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea Correspondence: Hye-Kyung Park; Hak Sun Yu, Tel +82+51-240-7000 ; +82+51-510-8022, Email ; Background: Repeated exposure to recombinant profilin from Acanthamoeba (rAc-PF) induces allergic airway responses in vitro and in vivo. Based on the role of toll-like receptors (TLRs) in allergic airway diseases, TLRs play a central role in innate immune responses and the adaptive immune system and regulate responses against antigens through antigen-specific receptors. In this study, we attempted to determine the molecular mechanisms underlying rAc-PF-induced allergic inflammatory responses. Methods: We determined the correlation between rAc-PF and TLRs and analyzed changes in allergic immune responses after blocking multiple TLR signaling under rAc-PF treatment conditions in vitro. We also compared allergic inflammatory responses in TLR2 knockout (KO) and wild-type (WT) mice. To investigate the effect of TLR2 on antigen prototyping and T cell activation in the inflammatory response induced by rAc-PF, we assessed maturation of BMDCs and polarization of naïve T cells by rAc-PF stimulation. Additionally, we compared changes in inflammation-related gene expression by rAc-PF treatment in primary lung epithelial cells isolated from TLR2 KO and WT mice. Results: The rAc-PF treatment was increased the expression level of TLR2 and 9 in vitro. But, there were not significantly differ the others TLRs expression by rAc-PF treated group. And then, the mRNA expression levels of inflammation-related genes were reduced in the TLR2 or TLR9 antagonist-treated groups compared to those in the rAc-PF alone, were no difference the treated with the other TLRs (TLR4, 6, and 7/8) antagonist. The difference was higher in the TLR2 antagonist group. Additionally, the levels of airway inflammatory disease indicators were lower in the TLR2 KO group than in the WT group after rAc-PF treatment. Furthermore, the expression of bone marrow-derived dendritic cell (BMDC) surface molecular markers following rAc-PF stimulation was lower in TLR2 KO mice than in WT mice, and TLR2 KO in BMDCs resulted in a remarkable decline in Th2/17-related cytokine production and Th2/17 subset differentiation. In addition, the expression levels of rAc-PF-induced inflammatory genes were reduced inTLR2 KO primary lung cells compared to those in normal primary lung cells. Conclusion: These results suggest that the rAc-PF-induced airway inflammatory response is regulated by TLR2 signaling. Keywords: rAc-PF, profilin, toll-like receptors, airway inflammation, T cell activation Toll-like receptors (TLRs) are fundamentals to sensing and responding to inflammation. TLRs are key innate immune sensors that respond to exogenous infectious ligands, pathogen-associated molecular patterns (PAMPs) of infectious ligands and damage-associated molecular patterns (DAMPs) of endogenous molecules. 1,2 The innate immune response initiated by TLRs is necessary to progress to the most adaptive immune response. TLR signaling is determined by the selective use of signaling adapters and the cells in which they are expressed. 2 Dendritic cells (DCs) have a unique ability to sense and present microbial antigens to prime naïve T cells. 3–5 TLR-mediated DC maturation plays an important role in the protective immunity conferred by protein-based vaccines. 6–8 For instance, lipoprotein BP1569, a novel TLR2 agonist, activates DCs via TLR2 and induces Th1/17 and IgG2a antibody responses in mice. 9 Several immune cell types, such as DCs, B cells, and CD4 + T cells, express TLRs. 9–13 TLR2 influences the initiation of adaptive immunity and regulates DC antigen presentation by altering the expression of surface molecules and cytokine secretion. Alternatively, TLR2 directly affects adaptive immune responses by regulating T cell subset polarization and antibody production. 14 TLR2 forms heterodimers with TLR2/1 and TLR2/6. The relationship between TLR2, airway diseases, and allergy prevalence remains uncertain, with recent meta-analyses revealing that rs3804099 may indicate of asthma risk or have no association. 15,16 However, TLR1 and TLR6 polymorphisms have been reported to be associated with allergic diseases, asthma, and atopy i -Abstract Truncated-
immunology